BackGlobus Medical Overview
Globus Medical Inc - Ordinary Shares - Class A

Globus Medical Target Price

See Globus Medical's analyst price targets ($95) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$75.19

Average Target Price

$95.1726.6% upside

6 analysts in the last 4 months

High: $115 | Low: $80

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-28UBS$829.1% upsideOpen
2026-07-16Truist FinancialRichard Newitter$10033% upsideOpen
2026-07-13RBC CapitalShagun Singh$11552.9% upsideOpen
2026-07-08BMO Capital$9425% upsideOpen
2026-07-08Stifel Nicolaus$806.4% upsideOpen
2026-06-15Piper Sandler$10033% upsideOpen
2026-05-08Needham$11755.6% upsideOpen
2026-05-08Wells FargoLarry Biegelsen$10337% upsideOpen
2026-02-25Truist FinancialRichard Newitter$11552.9% upsideOpen
2026-01-30Needham$11249% upsideOpen
2026-01-26Cowen & Co.$11046.3% upsideOpen
2026-01-09Canaccord Genuity$11249% upsideOpen
2026-01-08Piper SandlerMatt O'Brien$11552.9% upsideOpen
2025-12-17RBC CapitalShagun Singh$10033% upsideOpen
2025-12-17Canaccord GenuityCaitlin Cronin$10539.6% upsideOpen
2025-10-28Stifel NicolausThomas Stephan$6414.9% downsideOpen
2025-10-10RBC Capital$8817% upsideOpen
2024-12-02Morgan StanleyKallum Titchmarsh$10033% upsideOpen
2024-08-28BTIGRyan Zimmerman$772.4% upsideOpen
2024-08-07Wells FargoVik Chopra$783.7% upsideOpen
2024-07-15Morgan StanleyDrew Ranieri$715.6% downsideOpen
2024-05-29BTIGRyan Zimmerman$724.2% downsideOpen
2024-05-20Piper SandlerMatt O'Brien$806.4% upsideOpen
2024-03-18BTIGRyan Zimmerman$6020.2% downsideOpen
2023-09-19Stifel NicolausMathew Blackman$6118.9% downsideOpen
2023-01-06Morgan Stanley$783.7% upsideOpen
2022-12-20Truist Financial$8513% upsideOpen
2022-12-12Wells Fargo$829.1% upsideOpen
2022-08-05Piper Sandler$750.3% downsideOpen
2022-07-20Truist Financial$715.6% downsideOpen
2022-07-15Morgan Stanley$6217.5% downsideOpen
2022-05-12Morgan Stanley$689.6% downsideOpen
2022-05-11RBC Capital$732.9% downsideOpen
2022-05-11Needham$715.6% downsideOpen
2021-12-13Bank of America SecuritiesCraig Bijou$806.4% upsideOpen
2021-08-05Leerink PartnersRichard Newitter$9627.7% upsideOpen
2021-08-05CitigroupMatthew Henriksson$9323.7% upsideOpen
2021-08-05Canaccord GenuityKyle Rose$9019.7% upsideOpen
2021-05-05OppenheimerSteven Lichtman$795.1% upsideOpen

Globus Medical (GMED) FAQ

Globus Medical (GMED) currently reports a target price of $95. Use the charts on this page to explore Globus Medical's target price history and peer comparisons.

Analysts' average 12-month price target for Globus Medical is $95, about 26.6% upside from the current share price of $75.19. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $95, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Globus Medical, and consider following GMED for alerts when major investors trade the stock.

Globus Medical is classified in the Healthcare sector. On target price, it currently shows $95. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GMED with unrelated industries.